Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurological Disorder Drugs Market Size Growth Rate by Type: 2024 VS 2022 VS 2034
1.2.2 Antipsychotic
1.2.3 Hypnotic & Sedative
1.2.4 Analgesics
1.2.5 Anticoagulants
1.2.6 Others
1.3 Market by Application
1.3.1 Global Neurological Disorder Drugs Market Growth by Application: 2024 VS 2022 VS 2034
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neurological Disorder Drugs Market Perspective (2024-2034)
2.2 Neurological Disorder Drugs Growth Trends by Region
2.2.1 Global Neurological Disorder Drugs Market Size by Region: 2024 VS 2022 VS 2034
2.2.2 Neurological Disorder Drugs Historic Market Size by Region (2024-2024)
2.2.3 Neurological Disorder Drugs Forecasted Market Size by Region (2024-2034)
2.3 Neurological Disorder Drugs Market Dynamics
2.3.1 Neurological Disorder Drugs Industry Trends
2.3.2 Neurological Disorder Drugs Market Drivers
2.3.3 Neurological Disorder Drugs Market Challenges
2.3.4 Neurological Disorder Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neurological Disorder Drugs Players by Revenue
3.1.1 Global Top Neurological Disorder Drugs Players by Revenue (2024-2024)
3.1.2 Global Neurological Disorder Drugs Revenue Market Share by Players (2024-2024)
3.2 Global Neurological Disorder Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neurological Disorder Drugs Revenue
3.4 Global Neurological Disorder Drugs Market Concentration Ratio
3.4.1 Global Neurological Disorder Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurological Disorder Drugs Revenue in 2022
3.5 Neurological Disorder Drugs Key Players Head office and Area Served
3.6 Key Players Neurological Disorder Drugs Product Solution and Service
3.7 Date of Enter into Neurological Disorder Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neurological Disorder Drugs Breakdown Data by Type
4.1 Global Neurological Disorder Drugs Historic Market Size by Type (2024-2024)
4.2 Global Neurological Disorder Drugs Forecasted Market Size by Type (2024-2034)
5 Neurological Disorder Drugs Breakdown Data by Application
5.1 Global Neurological Disorder Drugs Historic Market Size by Application (2024-2024)
5.2 Global Neurological Disorder Drugs Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Neurological Disorder Drugs Market Size (2024-2034)
6.2 North America Neurological Disorder Drugs Market Growth Rate by Country: 2024 VS 2022 VS 2034
6.3 North America Neurological Disorder Drugs Market Size by Country (2024-2024)
6.4 North America Neurological Disorder Drugs Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neurological Disorder Drugs Market Size (2024-2034)
7.2 Europe Neurological Disorder Drugs Market Growth Rate by Country: 2024 VS 2022 VS 2034
7.3 Europe Neurological Disorder Drugs Market Size by Country (2024-2024)
7.4 Europe Neurological Disorder Drugs Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neurological Disorder Drugs Market Size (2024-2034)
8.2 Asia-Pacific Neurological Disorder Drugs Market Growth Rate by Region: 2024 VS 2022 VS 2034
8.3 Asia-Pacific Neurological Disorder Drugs Market Size by Region (2024-2024)
8.4 Asia-Pacific Neurological Disorder Drugs Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neurological Disorder Drugs Market Size (2024-2034)
9.2 Latin America Neurological Disorder Drugs Market Growth Rate by Country: 2024 VS 2022 VS 2034
9.3 Latin America Neurological Disorder Drugs Market Size by Country (2024-2024)
9.4 Latin America Neurological Disorder Drugs Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neurological Disorder Drugs Market Size (2024-2034)
10.2 Middle East & Africa Neurological Disorder Drugs Market Growth Rate by Country: 2024 VS 2022 VS 2034
10.3 Middle East & Africa Neurological Disorder Drugs Market Size by Country (2024-2024)
10.4 Middle East & Africa Neurological Disorder Drugs Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Neurological Disorder Drugs Introduction
11.1.4 Novartis Revenue in Neurological Disorder Drugs Business (2024-2024)
11.1.5 Novartis Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Detail
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Neurological Disorder Drugs Introduction
11.2.4 GlaxoSmithKline Revenue in Neurological Disorder Drugs Business (2024-2024)
11.2.5 GlaxoSmithKline Recent Development
11.3 Merck & Co.
11.3.1 Merck & Co. Company Detail
11.3.2 Merck & Co. Business Overview
11.3.3 Merck & Co. Neurological Disorder Drugs Introduction
11.3.4 Merck & Co. Revenue in Neurological Disorder Drugs Business (2024-2024)
11.3.5 Merck & Co. Recent Development
11.4 Bayer
11.4.1 Bayer Company Detail
11.4.2 Bayer Business Overview
11.4.3 Bayer Neurological Disorder Drugs Introduction
11.4.4 Bayer Revenue in Neurological Disorder Drugs Business (2024-2024)
11.4.5 Bayer Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Detail
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Neurological Disorder Drugs Introduction
11.5.4 AstraZeneca Revenue in Neurological Disorder Drugs Business (2024-2024)
11.5.5 AstraZeneca Recent Development
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Detail
11.6.2 Boehringer Ingelheim Business Overview
11.6.3 Boehringer Ingelheim Neurological Disorder Drugs Introduction
11.6.4 Boehringer Ingelheim Revenue in Neurological Disorder Drugs Business (2024-2024)
11.6.5 Boehringer Ingelheim Recent Development
11.7 Teva Pharmaceutical
11.7.1 Teva Pharmaceutical Company Detail
11.7.2 Teva Pharmaceutical Business Overview
11.7.3 Teva Pharmaceutical Neurological Disorder Drugs Introduction
11.7.4 Teva Pharmaceutical Revenue in Neurological Disorder Drugs Business (2024-2024)
11.7.5 Teva Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Neurological Disorder Drugs Market Size Growth Rate by Type (US$ Million): 2024 VS 2022 VS 2034
Table 2. Key Players of Antipsychotic
Table 3. Key Players of Hypnotic & Sedative
Table 4. Key Players of Analgesics
Table 5. Key Players of Anticoagulants
Table 6. Key Players of Others
Table 7. Global Neurological Disorder Drugs Market Size Growth by Application (US$ Million): 2024 VS 2022 VS 2034
Table 8. Global Neurological Disorder Drugs Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 9. Global Neurological Disorder Drugs Market Size by Region (2024-2024) & (US$ Million)
Table 10. Global Neurological Disorder Drugs Market Share by Region (2024-2024)
Table 11. Global Neurological Disorder Drugs Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 12. Global Neurological Disorder Drugs Market Share by Region (2024-2034)
Table 13. Neurological Disorder Drugs Market Trends
Table 14. Neurological Disorder Drugs Market Drivers
Table 15. Neurological Disorder Drugs Market Challenges
Table 16. Neurological Disorder Drugs Market Restraints
Table 17. Global Neurological Disorder Drugs Revenue by Players (2024-2024) & (US$ Million)
Table 18. Global Neurological Disorder Drugs Market Share by Players (2024-2024)
Table 19. Global Top Neurological Disorder Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurological Disorder Drugs as of 2022)
Table 20. Ranking of Global Top Neurological Disorder Drugs Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Neurological Disorder Drugs Revenue (CR5 and HHI) & (2024-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Neurological Disorder Drugs Product Solution and Service
Table 24. Date of Enter into Neurological Disorder Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Neurological Disorder Drugs Market Size by Type (2024-2024) & (US$ Million)
Table 27. Global Neurological Disorder Drugs Revenue Market Share by Type (2024-2024)
Table 28. Global Neurological Disorder Drugs Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 29. Global Neurological Disorder Drugs Revenue Market Share by Type (2024-2034)
Table 30. Global Neurological Disorder Drugs Market Size by Application (2024-2024) & (US$ Million)
Table 31. Global Neurological Disorder Drugs Revenue Market Share by Application (2024-2024)
Table 32. Global Neurological Disorder Drugs Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 33. Global Neurological Disorder Drugs Revenue Market Share by Application (2024-2034)
Table 34. North America Neurological Disorder Drugs Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 35. North America Neurological Disorder Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 36. North America Neurological Disorder Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 37. Europe Neurological Disorder Drugs Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 38. Europe Neurological Disorder Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 39. Europe Neurological Disorder Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 40. Asia-Pacific Neurological Disorder Drugs Market Size Growth Rate by Region (US$ Million): 2024 VS 2022 VS 2034
Table 41. Asia-Pacific Neurological Disorder Drugs Market Size by Region (2024-2024) & (US$ Million)
Table 42. Asia-Pacific Neurological Disorder Drugs Market Size by Region (2024-2034) & (US$ Million)
Table 43. Latin America Neurological Disorder Drugs Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 44. Latin America Neurological Disorder Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 45. Latin America Neurological Disorder Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 46. Middle East & Africa Neurological Disorder Drugs Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 47. Middle East & Africa Neurological Disorder Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 48. Middle East & Africa Neurological Disorder Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 49. Novartis Company Detail
Table 50. Novartis Business Overview
Table 51. Novartis Neurological Disorder Drugs Product
Table 52. Novartis Revenue in Neurological Disorder Drugs Business (2024-2024) & (US$ Million)
Table 53. Novartis Recent Development
Table 54. GlaxoSmithKline Company Detail
Table 55. GlaxoSmithKline Business Overview
Table 56. GlaxoSmithKline Neurological Disorder Drugs Product
Table 57. GlaxoSmithKline Revenue in Neurological Disorder Drugs Business (2024-2024) & (US$ Million)
Table 58. GlaxoSmithKline Recent Development
Table 59. Merck & Co. Company Detail
Table 60. Merck & Co. Business Overview
Table 61. Merck & Co. Neurological Disorder Drugs Product
Table 62. Merck & Co. Revenue in Neurological Disorder Drugs Business (2024-2024) & (US$ Million)
Table 63. Merck & Co. Recent Development
Table 64. Bayer Company Detail
Table 65. Bayer Business Overview
Table 66. Bayer Neurological Disorder Drugs Product
Table 67. Bayer Revenue in Neurological Disorder Drugs Business (2024-2024) & (US$ Million)
Table 68. Bayer Recent Development
Table 69. AstraZeneca Company Detail
Table 70. AstraZeneca Business Overview
Table 71. AstraZeneca Neurological Disorder Drugs Product
Table 72. AstraZeneca Revenue in Neurological Disorder Drugs Business (2024-2024) & (US$ Million)
Table 73. AstraZeneca Recent Development
Table 74. Boehringer Ingelheim Company Detail
Table 75. Boehringer Ingelheim Business Overview
Table 76. Boehringer Ingelheim Neurological Disorder Drugs Product
Table 77. Boehringer Ingelheim Revenue in Neurological Disorder Drugs Business (2024-2024) & (US$ Million)
Table 78. Boehringer Ingelheim Recent Development
Table 79. Teva Pharmaceutical Company Detail
Table 80. Teva Pharmaceutical Business Overview
Table 81. Teva Pharmaceutical Neurological Disorder Drugs Product
Table 82. Teva Pharmaceutical Revenue in Neurological Disorder Drugs Business (2024-2024) & (US$ Million)
Table 83. Teva Pharmaceutical Recent Development
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neurological Disorder Drugs Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Neurological Disorder Drugs Market Share by Type: 2022 VS 2034
Figure 3. Antipsychotic Features
Figure 4. Hypnotic & Sedative Features
Figure 5. Analgesics Features
Figure 6. Anticoagulants Features
Figure 7. Others Features
Figure 8. Global Neurological Disorder Drugs Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Neurological Disorder Drugs Market Share by Application: 2022 VS 2034
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Neurological Disorder Drugs Report Years Considered
Figure 13. Global Neurological Disorder Drugs Market Size (US$ Million), Year-over-Year: 2024-2034
Figure 14. Global Neurological Disorder Drugs Market Size, (US$ Million), 2024 VS 2022 VS 2034
Figure 15. Global Neurological Disorder Drugs Market Share by Region: 2022 VS 2034
Figure 16. Global Neurological Disorder Drugs Market Share by Players in 2022
Figure 17. Global Top Neurological Disorder Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurological Disorder Drugs as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Neurological Disorder Drugs Revenue in 2022
Figure 19. North America Neurological Disorder Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 20. North America Neurological Disorder Drugs Market Share by Country (2024-2034)
Figure 21. United States Neurological Disorder Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 22. Canada Neurological Disorder Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 23. Europe Neurological Disorder Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 24. Europe Neurological Disorder Drugs Market Share by Country (2024-2034)
Figure 25. Germany Neurological Disorder Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 26. France Neurological Disorder Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 27. U.K. Neurological Disorder Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 28. Italy Neurological Disorder Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 29. Russia Neurological Disorder Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 30. Nordic Countries Neurological Disorder Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 31. Asia-Pacific Neurological Disorder Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 32. Asia-Pacific Neurological Disorder Drugs Market Share by Region (2024-2034)
Figure 33. China Neurological Disorder Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 34. Japan Neurological Disorder Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 35. South Korea Neurological Disorder Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 36. Southeast Asia Neurological Disorder Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 37. India Neurological Disorder Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 38. Australia Neurological Disorder Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 39. Latin America Neurological Disorder Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 40. Latin America Neurological Disorder Drugs Market Share by Country (2024-2034)
Figure 41. Mexico Neurological Disorder Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 42. Brazil Neurological Disorder Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 43. Middle East & Africa Neurological Disorder Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 44. Middle East & Africa Neurological Disorder Drugs Market Share by Country (2024-2034)
Figure 45. Turkey Neurological Disorder Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 46. Saudi Arabia Neurological Disorder Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 47. Novartis Revenue Growth Rate in Neurological Disorder Drugs Business (2024-2024)
Figure 48. GlaxoSmithKline Revenue Growth Rate in Neurological Disorder Drugs Business (2024-2024)
Figure 49. Merck & Co. Revenue Growth Rate in Neurological Disorder Drugs Business (2024-2024)
Figure 50. Bayer Revenue Growth Rate in Neurological Disorder Drugs Business (2024-2024)
Figure 51. AstraZeneca Revenue Growth Rate in Neurological Disorder Drugs Business (2024-2024)
Figure 52. Boehringer Ingelheim Revenue Growth Rate in Neurological Disorder Drugs Business (2024-2024)
Figure 53. Teva Pharmaceutical Revenue Growth Rate in Neurological Disorder Drugs Business (2024-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed